BARCLAYS PLC - CAESARS ENTMT CORP ownership

CAESARS ENTMT CORP's ticker is CZRXXXX and the CUSIP is 127686103. A total of 106 filers reported holding CAESARS ENTMT CORP in Q3 2014. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CAESARS ENTMT CORP
ValueSharesWeighting
Q2 2020$15,966,000
-13.9%
1,316,171
-52.0%
0.01%
-20.0%
Q1 2020$18,551,000
-77.5%
2,744,359
-54.8%
0.02%
-67.4%
Q4 2019$82,629,000
+78.8%
6,075,638
+53.3%
0.05%
+58.6%
Q3 2019$46,216,000
-20.6%
3,963,691
-19.5%
0.03%
-19.4%
Q2 2019$58,216,000
-23.9%
4,925,129
-44.1%
0.04%
-32.1%
Q1 2019$76,534,000
-38.7%
8,807,131
-52.1%
0.05%
-44.8%
Q4 2018$124,885,000
+32.0%
18,392,527
+99.3%
0.10%
+47.7%
Q3 2018$94,609,000
+600.8%
9,229,996
+631.5%
0.06%
+490.9%
Q2 2018$13,501,000
-40.7%
1,261,845
-37.7%
0.01%
-38.9%
Q1 2018$22,778,000
-71.0%
2,024,605
-67.4%
0.02%
-71.9%
Q4 2017$78,502,000
+389.2%
6,205,707
+416.3%
0.06%
+300.0%
Q3 2017$16,048,000
-21.5%
1,201,963
-29.5%
0.02%
-27.3%
Q2 2017$20,447,000
+76.3%
1,703,942
+40.3%
0.02%
+83.3%
Q1 2017$11,596,000
+441.1%
1,214,386
+381.7%
0.01%
+300.0%
Q4 2016$2,143,000
-33.1%
252,085
-41.3%
0.00%0.0%
Q3 2016$3,203,000
+241.8%
429,805
+252.6%
0.00%
+200.0%
Q2 2016$937,000
-6.4%
121,901
-26.9%
0.00%
-50.0%
Q1 2016$1,001,000
-39.1%
166,831
-29.0%
0.00%
+100.0%
Q4 2015$1,645,000
+24.3%
234,900
-11.2%
0.00%0.0%
Q3 2015$1,323,000
-83.6%
264,414
-80.3%
0.00%
-88.9%
Q2 2015$8,067,000
+106.8%
1,344,527
+244.8%
0.01%
+80.0%
Q1 2015$3,900,000
-70.1%
389,940
-55.1%
0.01%
-58.3%
Q4 2014$13,023,000
+4.1%
868,117
-16.8%
0.01%0.0%
Q3 2014$12,514,000
+54.0%
1,042,924
+131.0%
0.01%
+33.3%
Q2 2014$8,126,000
-14.4%
451,407
-9.6%
0.01%
-10.0%
Q1 2014$9,490,000
-50.7%
499,379
-45.5%
0.01%
-47.4%
Q4 2013$19,254,000
+263.1%
916,825
+228.6%
0.02%
+171.4%
Q3 2013$5,302,000
+86.2%
279,002
+34.2%
0.01%
+75.0%
Q2 2013$2,848,000207,8990.00%
Other shareholders
CAESARS ENTMT CORP shareholders Q3 2014
NameSharesValueWeighting ↓
CIBC WORLD MARKETS CORP 38,696$1,793,5600.02%
View complete list of CAESARS ENTMT CORP shareholders